Navigation Links
New Colorectal Module From Simbionix Advances Laparoscopic Cancer Treatment
Date:11/26/2008

CLEVELAND, Ohio and LOD, Israel, November 26 /PRNewswire/ -- Simbionix USA Corp, an international company using leading edge simulation to advance clinical performance, announces the world-wide release of a breakthrough training simulation of the laparoscopic colorectal procedure.

Although minimally invasive surgical (MIS) techniques provide many advantages over traditional open surgery, surgeons have been slow to adopt laparoscopic colon resection, because it is a very challenging procedure to learn without potentially putting patients at risk. Colorectal resection is the most common treatment for colorectal cancer, which accounts for almost 10% of all cancer deaths in the US annually. The US National Institutes of Health (NIH) ranks colorectal cancer as the 4th most common type in the United States, with over 148,000 Americans diagnosed in 2008.

This new, virtual reality simulation, properly used, will significantly assist surgeons in mastering and perfecting their skills, in performing this critical cancer procedure, without posing a risk to patients during the learning process. The Laparoscopic Colorectal Procedure simulation joins the suite of training simulations available on Simbionix's critically acclaimed LAP Mentor(TM) which now offers training opportunities on seven different laparoscopic procedures and over 60 different patient scenarios.

"Our new laparoscopic colorectal module is definitely a revolution in the world of virtual reality medical simulation," explains Simbionix President, Ran Bronstein. "We've created a virtual 3D environment featuring the complex anatomical structures a surgeon would encounter in a real laparoscopic colorectal resection. Combined with the unique simulation capabilities that I believe only Simbionix can provide, the virtual module allows unlimited procedural interaction and is a definite leap forward in medical simulation."

The Simbionix Laparoscopic Colorectal Procedure simulation received international praise at the September 2008, 11th World Congress of Endoscopic Surgery and the Japanese Society of Endoscopic Surgery (JSES), and at the American College of Surgery (ACS) in San Francisco, CA in October. Professor Watanabe, head of the JSES, said: "It is very exciting to have a way of training how to perform and master this critical procedure. I am sure we will use it to train our surgeons."

Conor P. Delaney, Professor of Surgery, Chief, Division of Colorectal Surgery at Case Western Reserve University, is also excited about the new module. "The laparoscopic colorectal module will transform the way we teach laparoscopic colorectal surgery. I see this as an important part of training, where trainees learn the basic steps on a simple trainer, and then practice their first 20 cases on the Simbionix simulator. That way, by the time they need to perform in a clinical situation, they are already experienced with the procedure."

Simbionix is a global leader in medical simulation technology. Simbionix mission is to provide state of the art, computer-assisted metrics-based surgical simulation systems, and set the standard for minimally invasive surgical training and performance.

Simbionix products provide medical experts with hands-on training in a comprehensive array of MIS procedures, including; GI Endoscopy, Endourology, percutaneous access, advanced laparoscopic procedures and Endovascular procedures. http://www.simbionix.com

    Contact:

    Inbal Mazor
    VP Marketing
    Simbionix
    inbal@simbionix.com
    Tel: +1-216-229-2040


'/>"/>
SOURCE Simbionix Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. GeneNews appoints Canadian Colorectal Cancer Advisory Board
2. InNexus Biotechnology Announces New EGFR Antibody DXL1218 Targeting Colorectal Cancer and Announces $1.25 Million Private Placement
3. Poniard Announces Positive Incremental Efficacy and Safety Data from Phase 2 Picoplatin Trial in Patients With Metastatic Colorectal Cancer
4. NOTICE OF YM BIOSCIENCES CONFERENCE CALL TO DISCUSS PHASE II DATA FOR NIMOTUZUMAB IN METASTATIC COLORECTAL CANCER
5. GeneNews launches worlds first blood test for colorectal cancer screening
6. Genmab Initiates Zalutumumab Combination Study in Colorectal Cancer
7. Enterix Inc. Launches Its Point-of-Care Test for Colorectal Cancer Screening
8. GeneNews reports positive results from validation study of colorectal cancer biomarkers in late-breaking abstract at AACR
9. Quest Diagnostics Campaign Challenges Colorectal Cancer Screening Status Quo
10. Quest Diagnostics to Develop Blood Test to Aid in the Detection of Colorectal Cancer
11. Medicsight Welcomes U.S. Initiative to Reimburse CT Colonography for Early Detection of Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... 22, 2017 MarketNewsUpdates.com News Commentary  ... The traditional ... being pressured as of late due to the rise of ... has a dramatic impact on patient,s quality of life as ... for identifying new forms of opioid formulations that prevent abuse. ...
(Date:3/22/2017)... , March 22, 2017   Boston Biomedical , ... therapeutics designed to target cancer stemness pathways, today announced ... Andrews as Chief Executive Officer, effective April 24, ... Chiang J. Li , M.D., FACP, who has led ... ago. Under his leadership, Boston Biomedical has grown from ...
(Date:3/22/2017)... ... ... Premier executive recruitment firm, Slone Partners, is proud to have been named a Top ... Hunt Scanlon Media is one of the most respected life science publications in the ... sector. , “It is a great honor for Slone Partners to be part of ...
(Date:3/22/2017)... ... March 21, 2017 , ... Proper glycosylation is critical for ... increase and/or decrease in antibody-dependent cellular cytotoxicity or complement-dependent cytotoxicity, there is a ... , To meet this demand, the team at SCIEX has developed a ...
Breaking Biology Technology:
(Date:3/7/2017)... 7, 2017 Brandwatch , the leading social intelligence ... Prince,s Trust to uncover insights to support its reporting, help ... The UK,s leading youth charity will be using Brandwatch Analytics ... get a better understanding of the topics and issues that are ... ...
(Date:3/2/2017)... 2, 2017 Summary This report provides ... its partnering interests and activities since 2010. ... Read the full report: ... since 2010 report provides an in-depth insight into the partnering ... On demand company reports are prepared upon purchase ...
(Date:3/2/2017)... 2017 Australian stem cell and regenerative medicine ... signed an agreement with the Monash Lung Biology Network, ... Institute and Department of Pharmacology at Monash University, ... study to support the use of Cymerus™ mesenchymal stem ... Asthma is a chronic, long term lung condition ...
Breaking Biology News(10 mins):